Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies.

DEA wants to permanently anchor some COVID-era prescription regulations
The Drug Enforcement Administration is proposing the adoption of some COVID-era prescription practices around certain controlled substances. The agency published a framework to guide any such changes Jan. 17.
FDA regulator examines AI's growing influence in cardiology
Stephen Browning, the FDA's assistant director of hemodynamics and heart failure diagnostics, spoke with Cardiovascular Business about the agency's perspective on AI-enabled cardiovascular devices and many other topics.
Congressional Medicare advisors recommend tying radiologist pay increases to inflation
The American Medical Association this week criticized cuts to physician pay, while Medicare Advantage plans are slated to see a 4.33% boost.
Industry Watcher’s Digest
HHS isn’t waiting to see what its incoming secretary does before filling some key leadership positions.
FTC, DOJ and HHS release report warning of private equity consolidation in healthcare
The agencies said private equity firms are rolling up healthcare sectors through serialized purchases that fly under the radar of regulators, creating an unsustainable level of consolidation.

DEA wants to permanently anchor some COVID-era prescription regulations

The Drug Enforcement Administration is proposing the adoption of some COVID-era prescription practices around certain controlled substances. The agency published a framework to guide any such changes Jan. 17.

Stephen Browning, FDA assistant director for hemodynamic and heart failure diagnostics, explains the FDA perspectives and regulatory pathways for AI-enabled cardiovascular devices at TCT 2024.

FDA regulator examines AI's growing influence in cardiology

Stephen Browning, the FDA's assistant director of hemodynamics and heart failure diagnostics, spoke with Cardiovascular Business about the agency's perspective on AI-enabled cardiovascular devices and many other topics.

money dollar benjamin cash finance graph chart deal dollar

Congressional Medicare advisors recommend tying radiologist pay increases to inflation

The American Medical Association this week criticized cuts to physician pay, while Medicare Advantage plans are slated to see a 4.33% boost.

Industry Watcher’s Digest

HHS isn’t waiting to see what its incoming secretary does before filling some key leadership positions.

FTC, DOJ and HHS release report warning of private equity consolidation in healthcare

The agencies said private equity firms are rolling up healthcare sectors through serialized purchases that fly under the radar of regulators, creating an unsustainable level of consolidation.

FDA threatens Hologic with punishment for reported errors in making troubled breast device

Concerns stem from manufacturing and distribution of the BioZorb marker, with possible ramifications including "seizure, injunction and civil money penalties."

breast radiologist breast cancer mammography

Several states propose legislation to bolster coverage for supplemental breast imaging

Those proposing breast imaging-related measures so far in 2025 have included Connecticut, Florida, Hawaii, Indiana, Missouri, New York, South Carolina, Utah and Virginia, ACR reports.

Report highlights flaws in FDA rapid approval of Alzheimer drug

A new report from the Office of the Inspector General found the FDA failed to properly record meetings with drug manufacturers, ultimately approving drugs later shown to have safety and efficacy issues.